Dror Jerushalmi sells VLN shares via option exercises (VLN)

Rhea-AI Filing Summary

Dror Jerushalmi reported sales of Ordinary shares under the Employee Stock Option Plan. The Form 144 lists three sales: 12/05/2025 of 42,631 shares for $72,760.69, 01/02/2026 of 254,131 shares for $463,648.70, and 02/02/2026 of 199,758 shares for $308,719.22. The transactions are described as cash upon exercise and identify Oppenheimer & Co. Inc. as the broker.

Insights

Securities Compliance Officer

Routine Form 144 reporting of insider sales tied to option exercises.

The filing documents three separate dispositions by Dror Jerushalmi under the Employee Stock Option Plan with specific share counts and gross amounts on 12/05/2025, 01/02/2026, and 02/02/2026.

These entries show the method as cash upon exercise and list Oppenheimer & Co. Inc. as broker; timing and amounts are explicit in the excerpt. Subsequent filings may disclose net proceeds after fees or withholding.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 broad st. New York NY 10004	17802	27415.08	103050266	02/26/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	01/11/2019	Employee Stock Option Plan	Issuer			17802	02/26/2026	Cash - Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Dror Jerushalmi 8 HANAGAR ST. POB 7152 HOD HASHARON L3 4501309	Ordinary	12/05/2025	42631	72760.69
Dror Jerushalmi 8 HANAGAR ST. POB 7152 HOD HASHARON L3 4501309	Ordinary	01/02/2026	254131	463648.70
Dror Jerushalmi 8 HANAGAR ST. POB 7152 HOD HASHARON L3 4501309	Ordinary	02/02/2026	199758	308719.22

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What sales did Dror Jerushalmi report for VLN in this Form 144?

The filing lists three sales: 42,631 shares on 12/05/2025, 254,131 shares on 01/02/2026, and 199,758 shares on 02/02/2026. Each sale shows an associated gross dollar amount in the excerpt.

Which broker handled the reported VLN transactions?

Oppenheimer & Co. Inc. is named as the broker in the excerpt. The filing also identifies the transactions as made under the Employee Stock Option Plan with cash upon exercise listed as the method.

Are the dollar amounts for each VLN sale shown in the Form 144 excerpt?

Yes. The excerpt shows gross amounts: $72,760.69 for 12/05/2025, $463,648.70 for 01/02/2026, and $308,719.22 for 02/02/2026 linked to the respective share counts.

Do these Form 144 entries indicate how proceeds were used or net proceeds?

The excerpt lists gross cash amounts upon exercise but does not state net proceeds or uses. The filing identifies the sales and gross amounts; any fees, withholdings, or allocation of proceeds are not shown in the provided excerpt.